A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Advanced Solid Tumors · Breast Cancer · Non Small Cell Lung Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Anhui Provincial Hospital(The First Affiliated Hospital of Ustc), Hefei, Anhui, China

  • Fujian Cancer Hospital, Fuzhou, Fujian, China

  • Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

  • Meizhou People's Hospital(Huangtang Hospital)Meizhou Academy of Medical Sciences, Meizhou, Guangdong, China

  • Ghang xi Medical University Cancer Hospital, Nanning, Guangxi, China

  • Affiliated Hospital Of Hebei University, Baoding, Hebei, China

  • Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China

  • Anyang Cancer Hospital, Anyang, Henan, China

  • The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China

  • Xiangyang Central Hospital, Xiangyang, Hubei, China

  • The First People's Hospital of Changde City, Changde, Hunan, China

  • Jiangsu Province Hospital(The First Affiliated Hospital With Nanjing Medical University, Jiangsu Women And Children Health Hospital), Nanjing, Jiangsu, China

  • Jiangxi Cancer Hospital, Nanchang, Jiangxi, China

  • Affiliated Zhongshan Hospital Dalian University, Dalian, Liaoning, China

  • Liaoning cancer hospital &institute, Shenyang, Liaoning, China

  • Affiliated Zhongshan Hospital Dalian University, Jinan, Shandong, China

  • Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China

  • Shanxi Cancer Hospital, Taiyuan, Shanxi, China

  • Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital, Sichuan, Sichuan, China

  • Tianjin Cancer Hospital Airport Hospital, Tianjin, Tianjin Municipality, China